126 related articles for article (PubMed ID: 25057175)
1. Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer.
Lindström LS; Li J; Lee M; Einbeigi Z; Hartman M; Hall P; Czene K
Ann Oncol; 2014 Oct; 25(10):1966-1972. PubMed ID: 25057175
[TBL] [Abstract][Full Text] [Related]
2. Timing of familial breast cancer in sisters.
Rebora P; Czene K; Reilly M
J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
[TBL] [Abstract][Full Text] [Related]
3. Is breast cancer prognosis inherited?
Hartman M; Lindström L; Dickman PW; Adami HO; Hall P; Czene K
Breast Cancer Res; 2007; 9(3):R39. PubMed ID: 17598882
[TBL] [Abstract][Full Text] [Related]
4. Evidence for familial clustering in breast cancer age of onset.
Von Holle A; O'Brien KM; Sandler DP; Weinberg CR
Int J Epidemiol; 2021 Mar; 50(1):97-104. PubMed ID: 33247915
[TBL] [Abstract][Full Text] [Related]
5. Age at onset as an indicator of familial risk of breast cancer.
Claus EB; Risch NJ; Thompson WD
Am J Epidemiol; 1990 Jun; 131(6):961-72. PubMed ID: 2188501
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer prognosis is inherited independently of patient, tumor and treatment characteristics.
Verkooijen HM; Hartman M; Usel M; Benhamou S; Neyroud-Caspar I; Czene K; Vlastos G; Chappuis PO; Bouchardy C; Rapiti E
Int J Cancer; 2012 May; 130(9):2103-10. PubMed ID: 21630259
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Breast Cancer Family History, Estrogen Receptor Status, and Breast Cancer Outcomes in Sweden.
Zhang Y; Wang QL; Zeng E; He W; Czene K
JAMA Netw Open; 2023 Jun; 6(6):e2318053. PubMed ID: 37310740
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy history and risk of premenopausal breast cancer-a nested case-control study.
Hajiebrahimi M; Cnattingius S; Lambe M; Bahmanyar S
Int J Epidemiol; 2016 Jun; 45(3):816-24. PubMed ID: 26559546
[TBL] [Abstract][Full Text] [Related]
9. Is genetic background important in lung cancer survival?
Lindström LS; Hall P; Hartman M; Wiklund F; Czene K
PLoS One; 2009 May; 4(5):e5588. PubMed ID: 19478952
[TBL] [Abstract][Full Text] [Related]
10. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
Chen HL; Zhou MQ; Tian W; Meng KX; He HF
PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
[TBL] [Abstract][Full Text] [Related]
11. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2017 Sep; 165(2):391-402. PubMed ID: 28601929
[TBL] [Abstract][Full Text] [Related]
12. Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.
Dar H; Johansson A; Nordenskjöld A; Iftimi A; Yau C; Perez-Tenorio G; Benz C; Nordenskjöld B; Stål O; Esserman LJ; Fornander T; Lindström LS
JAMA Netw Open; 2021 Jun; 4(6):e2114904. PubMed ID: 34190995
[TBL] [Abstract][Full Text] [Related]
13. Young-Onset Breast Cancer Outcomes by Time Since Recent Childbirth in Utah.
Zhang Z; Bassale S; Jindal S; Fraser A; Guinto E; Anderson W; Mori M; Smith KR; Schedin P
JAMA Netw Open; 2022 Oct; 5(10):e2236763. PubMed ID: 36239933
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing survival among patients with HER2-positive metastatic breast cancer treated with trastuzumab.
Blanchette PS; Desautels DN; Pond GR; Bartlett JMS; Nofech-Mozes S; Yaffe MJ; Pritchard KI
Breast Cancer Res Treat; 2018 Jul; 170(1):169-177. PubMed ID: 29520532
[TBL] [Abstract][Full Text] [Related]
15. Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.
Liu YR; Jiang YZ; Yu KD; Shao ZM
Ann Surg Oncol; 2015 Apr; 22(4):1102-10. PubMed ID: 25249260
[TBL] [Abstract][Full Text] [Related]
16. Adolescent Pregnancy Outcomes Among Sisters and Mothers: A Population-Based Retrospective Cohort Study Using Linkable Administrative Data.
Wall-Wieler E; Roos LL; Nickel NC
Public Health Rep; 2018; 133(1):100-108. PubMed ID: 29262270
[TBL] [Abstract][Full Text] [Related]
17. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Breast Cancer Res; 2018 Nov; 20(1):142. PubMed ID: 30458873
[TBL] [Abstract][Full Text] [Related]
18. Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women.
Keegan TH; Press DJ; Tao L; DeRouen MC; Kurian AW; Clarke CA; Gomez SL
Breast Cancer Res; 2013; 15(5):R95. PubMed ID: 24131591
[TBL] [Abstract][Full Text] [Related]
19. Differences in survival for patients with familial and sporadic cancer.
Lee M; Reilly M; Lindström LS; Czene K
Int J Cancer; 2017 Feb; 140(3):581-590. PubMed ID: 27759937
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of young age (<35 years) by subtype based on ER, PR, and HER2 status in breast cancer: a nationwide registry-based study.
Kim EK; Noh WC; Han W; Noh DY
World J Surg; 2011 Jun; 35(6):1244-53. PubMed ID: 21472372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
